-
公开(公告)号：EP3381930A1
公开(公告)日：2018-10-03
申请号：EP18160722.7
申请日：2005-07-07
IPC分类号： C07K14/005 , A61K39/00 , A61K38/00 , A61K39/12
CPC分类号： C07K14/005 , A61K39/00 , A61K39/12 , A61K39/155 , A61K2039/505 , A61K2039/575 , A61K2039/6075 , C07K14/07 , C07K14/115 , C07K16/1027 , C07K2319/40 , C12N7/00 , C12N2710/24141 , C12N2760/18222 , C12N2760/18234 , C12N2760/18271 , G01N33/56983 , G01N33/6854
摘要： This invention relates to soluble forms of G glycoprotein from Hendra and Nipah virus. In particular, this invention relates to compositions comprising soluble forms of G glycoprotein from Hendra and Nipah virus and also to diagnostic and therapeutic methods using the soluble forms of G glycoprotein from Hendra and Nipah virus. Further, the invention relates to therapeutic antibodies including neutralizing antibodies, and vaccines for the prevention and treatment of infection by Hendra and Nipah viruses.
-
公开(公告)号：EP2437772B1
公开(公告)日：2017-12-06
申请号：EP10784168.6
申请日：2010-06-04
申请人： 13Therapeutics, Inc.
IPC分类号： A61K38/16 , A61K38/02 , A61K38/10 , C07K14/00 , C07K7/08 , A61P29/00 , A61P17/06 , A61P17/00 , A61P19/02
CPC分类号： A61K39/285 , A61K38/00 , C07K7/06 , C07K7/08 , C07K14/005 , C07K14/07 , C07K14/47 , C07K2319/10 , C12N2710/24122
摘要： Peptides for the treatment of inflammation, and therapeutic uses and methods of using the same are disclosed. Peptides including a transducing sequence are effective for inhibiting cytokine activity and TNF-alpha secretion through interaction with toll-like receptors. Experiments are described illustrating the efficacy of the compounds in treating otitis media.
-
3.发明授权
公开(公告)号：EP1789593B1
公开(公告)日：2017-03-15
申请号：EP05857509.3
申请日：2005-07-07
IPC分类号： C07K14/005
CPC分类号： C07K14/005 , A61K39/00 , A61K39/12 , A61K39/155 , A61K2039/505 , A61K2039/575 , A61K2039/6075 , C07K14/07 , C07K14/115 , C07K16/1027 , C07K2319/40 , C12N7/00 , C12N2710/24141 , C12N2760/18222 , C12N2760/18234 , C12N2760/18271 , G01N33/56983 , G01N33/6854
摘要： This invention relates to soluble forms of G glycoprotein from Hendra and Nipah virus. In particular, this invention relates to compositions comprising soluble forms of G glycoprotein from Hendra and Nipah virus and also to diagnostic and therapeutic methods using the soluble forms of G glycoprotein from Hendra and Nipah virus. Further, the invention relates to therapeutic antibodies including neutralizing antibodies, and vaccines for the prevention and treatment of infection by Hendra and Nipah viruses.
摘要翻译： 本发明涉及来自Hendra和Nipah病毒的G糖蛋白的可溶形式。 特别地，本发明涉及包含来自Hendra和Nipah病毒的G糖蛋白的可溶形式的组合物，还涉及使用Hendra和Nipah病毒的G糖蛋白的可溶形式的诊断和治疗方法。 此外，本发明涉及包括中和抗体的治疗性抗体和用于预防和治疗Hendra和Nipah病毒感染的疫苗。
-
公开(公告)号：EP2495252A2
公开(公告)日：2012-09-05
申请号：EP12157071.7
申请日：2005-07-07
IPC分类号： C07K14/115 , A61K39/155 , C12N15/62
CPC分类号： C07K14/005 , A61K39/00 , A61K39/12 , A61K39/155 , A61K2039/505 , A61K2039/575 , A61K2039/6075 , C07K14/07 , C07K14/115 , C07K16/1027 , C07K2319/40 , C12N7/00 , C12N2710/24141 , C12N2760/18222 , C12N2760/18234 , C12N2760/18271 , G01N33/56983 , G01N33/6854
摘要： This invention relates to soluble forms of G glycoprotein from Hendra and Nipah virus. In particular, this invention relates to compositions comprising soluble forms of G glycoprotein from Hendra and Nipah virus and also to diagnostic and therapeutic methods using the soluble forms of G glycoprotein from Hendra and Nipah virus. Further, the invention relates to therapeutic antibodies including neutralizing antibodies, and vaccines for the prevention and treatment of infection by Hendra and Nipah viruses.
-
公开(公告)号：EP1789593A2
公开(公告)日：2007-05-30
申请号：EP05857509.3
申请日：2005-07-07
IPC分类号： C12Q1/70
CPC分类号： C07K14/005 , A61K39/00 , A61K39/12 , A61K39/155 , A61K2039/505 , A61K2039/575 , A61K2039/6075 , C07K14/07 , C07K14/115 , C07K16/1027 , C07K2319/40 , C12N7/00 , C12N2710/24141 , C12N2760/18222 , C12N2760/18234 , C12N2760/18271 , G01N33/56983 , G01N33/6854
摘要： This invention relates to soluble forms of G glycoprotein from Hendra and Nipah virus. In particular, this invention relates to compositions comprising soluble forms of G glycoprotein from Hendra and Nipah virus and also to diagnostic and therapeutic methods using the soluble forms of G glycoprotein from Hendra and Nipah virus. Further, the invention relates to therapeutic antibodies including neutralizing antibodies, and vaccines for the prevention and treatment of infection by Hendra and Nipah viruses.
-
公开(公告)号：EP2495252B1
公开(公告)日：2018-04-18
申请号：EP12157071.7
申请日：2005-07-07
CPC分类号： C07K14/005 , A61K39/00 , A61K39/12 , A61K39/155 , A61K2039/505 , A61K2039/575 , A61K2039/6075 , C07K14/07 , C07K14/115 , C07K16/1027 , C07K2319/40 , C12N7/00 , C12N2710/24141 , C12N2760/18222 , C12N2760/18234 , C12N2760/18271 , G01N33/56983 , G01N33/6854
摘要： This invention relates to soluble forms of G glycoprotein from Hendra and Nipah virus. In particular, this invention relates to compositions comprising soluble forms of G glycoprotein from Hendra and Nipah virus and also to diagnostic and therapeutic methods using the soluble forms of G glycoprotein from Hendra and Nipah virus. Further, the invention relates to therapeutic antibodies including neutralizing antibodies, and vaccines for the prevention and treatment of infection by Hendra and Nipah viruses.
-
公开(公告)号：EP2437772A4
公开(公告)日：2013-07-10
申请号：EP10784168
申请日：2010-06-04
申请人： 13THERAPEUTICS INC
IPC分类号： A61K38/16 , A61K38/02 , A61K38/10 , A61P17/00 , A61P17/06 , A61P19/02 , A61P29/00 , C07K7/08 , C07K14/00
CPC分类号： A61K39/285 , A61K38/00 , C07K7/06 , C07K7/08 , C07K14/005 , C07K14/07 , C07K14/47 , C07K2319/10 , C12N2710/24122
摘要： Peptides for the treatment of inflammation, and therapeutic uses and methods of using the same are disclosed. Peptides including a transducing sequence are effective for inhibiting cytokine activity and TNF-alpha secretion through interaction with toll-like receptors. Experiments are described illustrating the efficacy of the compounds in treating otitis media.
-
8.发明公开Soluble forms of hendra and nipah virus G glycoprotein 有权LöslicheFormen von Hendra-和Nipah-Virus-G-Glycoprotein
公开(公告)号：EP2495252A3
公开(公告)日：2013-05-01
申请号：EP12157071.7
申请日：2005-07-07
CPC分类号： C07K14/005 , A61K39/00 , A61K39/12 , A61K39/155 , A61K2039/505 , A61K2039/575 , A61K2039/6075 , C07K14/07 , C07K14/115 , C07K16/1027 , C07K2319/40 , C12N7/00 , C12N2710/24141 , C12N2760/18222 , C12N2760/18234 , C12N2760/18271 , G01N33/56983 , G01N33/6854
摘要： This invention relates to soluble forms of G glycoprotein from Hendra and Nipah virus. In particular, this invention relates to compositions comprising soluble forms of G glycoprotein from Hendra and Nipah virus and also to diagnostic and therapeutic methods using the soluble forms of G glycoprotein from Hendra and Nipah virus. Further, the invention relates to therapeutic antibodies including neutralizing antibodies, and vaccines for the prevention and treatment of infection by Hendra and Nipah viruses.
摘要翻译： 本发明涉及来自Hendra和Nipah病毒的G糖蛋白的可溶形式。 特别地，本发明涉及包含来自Hendra和Nipah病毒的G糖蛋白的可溶形式的组合物，还涉及使用Hendra和Nipah病毒的G糖蛋白的可溶形式的诊断和治疗方法。 此外，本发明涉及包括中和抗体的治疗性抗体和用于预防和治疗Hendra和Nipah病毒感染的疫苗。
-
公开(公告)号：EP2437772A1
公开(公告)日：2012-04-11
申请号：EP10784168.6
申请日：2010-06-04
申请人： 13therapeutics, Inc.
IPC分类号： A61K38/16 , A61K38/02 , A61K38/10 , C07K14/00 , C07K7/08 , A61P29/00 , A61P17/06 , A61P17/00 , A61P19/02
CPC分类号： A61K39/285 , A61K38/00 , C07K7/06 , C07K7/08 , C07K14/005 , C07K14/07 , C07K14/47 , C07K2319/10 , C12N2710/24122
摘要： Peptides for the treatment of inflammation, and therapeutic uses and methods of using the same are disclosed. Peptides including a transducing sequence are effective for inhibiting cytokine activity and TNF-alpha secretion through interaction with toll-like receptors. Experiments are described illustrating the efficacy of the compounds in treating otitis media.
-
10.发明公开SOLUBLE FORMS OF HENDRA AND NIPAH VIRUS G GLYCOPROTEIN 有权NIPAH-VIRUS-G-GLYCOPROTEIN的LÖSLICHEFORMEN VON HENDRA
公开(公告)号：EP1789593A4
公开(公告)日：2009-12-23
申请号：EP05857509
申请日：2005-07-07
CPC分类号： C07K14/005 , A61K39/00 , A61K39/155 , A61K2039/505 , A61K2039/575 , A61K2039/6075 , C07K14/07 , C07K14/115 , C07K16/1027 , C07K2319/40 , C12N7/00 , C12N2710/24141 , C12N2760/18222 , C12N2760/18234 , C12N2760/18271 , G01N33/56983 , G01N33/6854
摘要： This invention relates to soluble forms of G glycoprotein from Hendra and Nipah virus. In particular, this invention relates to compositions comprising soluble forms of G glycoprotein from Hendra and Nipah virus and also to diagnostic and therapeutic methods using the soluble forms of G glycoprotein from Hendra and Nipah virus. Further, the invention relates to therapeutic antibodies including neutralizing antibodies, and vaccines for the prevention and treatment of infection by Hendra and Nipah viruses.
摘要翻译： 本发明涉及来自Hendra和Nipah病毒的G糖蛋白的可溶形式。 特别地，本发明涉及包含来自Hendra和Nipah病毒的G糖蛋白的可溶形式的组合物，还涉及使用Hendra和Nipah病毒的G糖蛋白的可溶形式的诊断和治疗方法。 此外，本发明涉及包括中和抗体的治疗性抗体和用于预防和治疗Hendra和Nipah病毒感染的疫苗。
-
-
-
-
-
-
-
-
-
搜索结果
10 条记录 (耗时 0.013 秒)
